Visual Impairment as a Function of Visual Acuity in Both Eyes and Its Impact on Patient Reported Preferences

被引:41
作者
Finger, Robert P. [1 ,2 ]
Fenwick, Eva [1 ]
Hirneiss, Christoph W. [4 ]
Hsueh, Arthur [5 ]
Guymer, Robyn H. [1 ]
Lamoureux, Ecosse L. [1 ,3 ]
Keeffe, Jill E. [1 ]
机构
[1] Univ Melbourne, Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, Melbourne, Vic, Australia
[2] Univ Bonn, Dept Ophthalmol, Bonn, Germany
[3] Natl Univ Singapore, Singapore Eye Res Inst, Singapore 117548, Singapore
[4] Univ Munich, Dept Ophthalmol, Munich, Germany
[5] Univ Melbourne, Sch Populat Hlth, Ctr Hlth Policy Programs & Econ, Melbourne, Vic, Australia
来源
PLOS ONE | 2013年 / 8卷 / 12期
基金
英国医学研究理事会; 澳大利亚国家健康与医学研究理事会;
关键词
QUALITY-OF-LIFE; MACULAR DEGENERATION; CONTRAST SENSITIVITY; COST-EFFECTIVENESS; VISION; UTILITY; VALUATIONS; SURGERY; EUROQOL;
D O I
10.1371/journal.pone.0081042
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Purpose: To assess the impact of VA loss on patient reported utilities taking both eyes into account compared to taking only the better or the worse eye into account. Methods: In this cross-sectional study 1085 patients and 254 controls rated preferences with the generic health-related (EQ-5D; n = 868) and vision-specific (Vision and Quality of Life Index (VisQoL); n = 837) multi-attribute utility instruments (MAUIs). Utilities were calculated for three levels of VA in the better and worse eyes, as well as for 6 different vision states based on combinations of the better and worse eye VA. Results: Using the VisQoL, utility scores decreased significantly with deteriorating vision in both the better and worse eyes when analysed separately. When stratified by the 6 vision states, VisQoL utilities decreased as VA declined in the worse eye despite stable VA in the better eye. Differences in VisQoL scores were statistically significant for cases where the better eye had no vision impairment and the worse seeing fellow eye had mild, moderate or severe vision impairment. In contrast, the EQ-5D failed to capture changes in better or worse eye VA, or any of the six vision states. Conclusions: Calculating utilities based only on better eye VA or using a generic MAUI is likely to underestimate the impact of vision impairment, particularly when the better eye has no or little VA loss and the worse eye is moderately to severely visually impaired. These findings have considerable implications for the assessment of overall visual impairment as well as economic evaluations within eye health.
引用
收藏
页数:5
相关论文
共 26 条
[1]   Using contrast sensitivity to estimate the cost-effectiveness of verteporfin in patients with predominantly classic age-related macular degeneration [J].
Bansback, N. ;
Davis, S. ;
Brazier, J. .
EYE, 2007, 21 (12) :1455-1463
[2]   Determinants of health related quality of life and health state utility in patients with age related macular degeneration: the association of contrast sensitivity and visual acuity [J].
Bansback, N. ;
Czoski-Murray, C. ;
Carlton, J. ;
Lewis, G. ;
Hughes, L. ;
Espallargues, M. ;
Brand, C. ;
Brazier, J. .
QUALITY OF LIFE RESEARCH, 2007, 16 (03) :533-543
[3]  
Bourne R, 2012, ARCH OPHTHALMOL-CHIC, V130, P645, DOI 10.1001/archophthalmol.2012.1032
[4]   Vision-Related Function after Ranibizumab Treatment by Better- or Worse-Seeing Eye Clinical Trial Results from MARINA and ANCHOR [J].
Bressler, Neil M. ;
Chang, Tom S. ;
Suner, Ivan J. ;
Fine, Jennifer T. ;
Dolan, Chantal M. ;
Ward, James ;
Ianchulev, Tsontcho .
OPHTHALMOLOGY, 2010, 117 (04) :747-U124
[5]  
Brown G C, 1999, Trans Am Ophthalmol Soc, V97, P473
[6]  
Brown G C, 2001, Trans Am Ophthalmol Soc, V99, P199
[7]  
Brown M M, 1999, Curr Opin Ophthalmol, V10, P221, DOI 10.1097/00055735-199906000-00012
[8]   Quality of life associated with unilateral and bilateral good vision [J].
Brown, MM ;
Brown, GC ;
Sharma, S ;
Busbee, B ;
Brown, H .
OPHTHALMOLOGY, 2001, 108 (04) :643-647
[9]   Logical inconsistencies in survey respondents' health state valuations - a methodological challenge for estimating social tariffs [J].
Devlin, NJ ;
Hansen, P ;
Kind, P ;
Williams, A .
HEALTH ECONOMICS, 2003, 12 (07) :529-544
[10]   Modeling valuations for EuroQol health states [J].
Dolan, P .
MEDICAL CARE, 1997, 35 (11) :1095-1108